Trials / Completed
CompletedNCT02066545
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 327 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety and efficacy of once-daily topical application of CLS001 1%, 1.75% and 2.5% topical gel compared to vehicle topical gel in subjects with inflammatory acne vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CLS001 Topical Gel | |
| DRUG | CLS001 Topical Gel Vehicle |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-11-01
- First posted
- 2014-02-19
- Last updated
- 2015-09-17
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02066545. Inclusion in this directory is not an endorsement.